Finance

Beta
Lists
CE:NYSE
Celanese Corp
$48.04
-0.19%
(-0.090) 1D
$48.04
0.00% (0.00)
After hours
Closed: Jun 24, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CE...
Open
$48.04
High
$48.25
Low
$46.61
Mkt. cap
5.27B
Avg. vol.
1.66M
Volume
8.00
Dividend
0.25%
Quarterly dividend
$0.03
Ex-dividend date
Apr 27, 2026
52-wk high
$70.70
52-wk low
$35.13
EPS
-$10.00
Beta
0.73
Shares outstanding
109.66M
No. of employees
11K
Open
$48.04
High
$48.25
Low
$46.61
Mkt. cap
5.27B
Avg. vol.
1.66M
Volume
8.00
Dividend
0.25%
Quarterly dividend
$0.03
Ex-dividend date
Apr 27, 2026
52-wk high
$70.70
52-wk low
$35.13
EPS
-$10.00
Beta
0.73
Shares outstanding
109.66M
No. of employees
11K
News stories
From sources across the web
Profile
Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the world's leading producer of acetic acid, producing about 1.95 million tonnes per year, representing approximately 20% of global production. Celanese is also the world's largest producer of vinyl acetate monomer. Celanese operates 25 production plants and six research centers in 11 countries, mainly in North America, Europe, and Asia. The company owns and operates the world's three largest acetic acid plants: one in the Clear Lake area of Pasadena, Texas, one on Jurong Island in Singapore, and a third in Nanjing, China. During 2018 Celanese along with 90 additional Fortune 500 companies "paid an effective federal tax rate of 0% or less" as a result of Donald Trump's Tax Cuts and Jobs Act of 2017 Wikipedia
About Celanese Corp
CEOScott Richardson
Employees11.4K
Founded1918
HeadquartersIrving, Texas, United States
SectorSpeciality chemicals
Analyst Ratings
Based on 13 analysts giving stock ratings to CE in the past 3 months
Buy
Buy
7
Hold
6
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CE in the last 3 months.
Highest
Current $48.04
$86.00 (+79.02%)
Average
$72.00 (+49.88%)
Lowest
$63.00 (+31.14%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Patrick Cunningham
Citi
Buy
Maintained
$68.00
+41.5%
06/24/2026
Laurence Alexander
Jefferies
Buy
Maintained
$86.00
+79%
06/16/2026
Hassan Ahmed
Alembic Global
Buy
Maintained
$75.00
+56.1%
06/03/2026
Michael Sison
Wells Fargo
Buy
Reiterated
$80.00
+66.5%
05/27/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Upgraded
$68.00
+41.5%
05/12/2026
Arun Viswanathan
RBC Capital
Hold
Maintained
$68.00
+41.5%
05/08/2026
Matthew DeYoe
Bank of America Securities
Buy
Maintained
-
-
05/07/2026
Eric Boyes
Evercore ISI
Hold
Maintained
$63.00
+31.1%
05/07/2026
John Roberts CFA
Mizuho Securities
Hold
Maintained
$65.00
+35.3%
05/06/2026
John McNulty
BMO Capital
Hold
Maintained
$80.00
+66.5%
05/06/2026
Vincent Andrews
Morgan Stanley
Hold
Reiterated
$72.00
+49.9%
05/05/2026
Salvator Tiano
Bank of America Securities
Buy
Maintained
$75.00
+56.1%
04/21/2026
Joshua Spector
UBS
Hold
Maintained
$64.00
+33.2%
04/09/2026
Ghansham Panjabi
Robert W. Baird
Buy
Maintained
$75.00
+56.1%
03/27/2026
Matthew Blair
Tudor Pickering
Buy
Upgraded
-
-
03/09/2026
Kevin McCarthy
Vertical Research
Buy
Upgraded
$60.00
+24.9%
03/09/2026
Aleksey Yefremov
KeyBanc
Buy
Maintained
$62.00
+29.1%
02/19/2026
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.85 / $0.90
-5.19%miss
Revenue / Est. (USD)
2.34B / 2.35B
-0.41%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.53B
2.42B
2.20B
2.34B
Cost of goods sold
2.00B
1.90B
1.77B
1.85B
Cost of revenue
2.00B
1.90B
1.77B
1.85B
Research and development expenses
31.00M
31.00M
32.00M
28.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
214.00M
229.00M
173.00M
221.00M
Operating expense
287.00M
302.00M
245.00M
289.00M
Total operating expenses
2.29B
2.20B
2.02B
2.14B
Operating income
245.00M
219.00M
189.00M
198.00M
Other non operating income
1.00M
4.00M
-
1.00M
EBT including unusual items
130.00M
-1.36B
13.00M
82.00M
EBT excluding unusual items
152.00M
134.00M
102.00M
73.00M
Income tax expense
-77.00M
-7.00M
-15.00M
33.00M
Effective tax rate
-59.23%
0.51%
-115.38%
40.24%
Other operating expenses
-
-
-
-
Net income
194.00M
-1.36B
19.00M
44.00M
Net profit margin
7.66%
-56.10%
0.86%
1.88%
Earnings per share
1.44
1.34
0.67
0.85
Interest and investment income
48.00M
47.00M
46.00M
10.00M
Interest expense
-177.00M
-177.00M
-177.00M
-183.00M
Net interest expenses
-129.00M
-130.00M
-131.00M
-173.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
427.00M
337.00M
441.00M
377.00M
Gain or loss from assets sale
1.00M
5.00M
2.00M
-48.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more